Relapses, also referred to as exacerbations, attacks, flare-ups, episodes, or bouts, are initially experienced by most people diagnosed with multiple sclerosis (MS). Relapses occur with relapsing-remitting and sometimes secondary-progressive forms […]
Read News ArticleAuthor: Hoff Communications
Diagnosing MS and Evaluating Disease Activity
Diagnosing and evaluating MS disease activity is most reliably done by neurologists through a neurological history and examination. Tests that can indicate MS and rule out “MS mimickers” (other diseases […]
Read News ArticlePossible Causes of MS
Researchers have studied a variety of possible causes for multiple sclerosis (MS), and a combination of factors appears to be involved. A popular theory looks at commonly known slow-acting viruses […]
Read News ArticleTypes of MS
Multiple sclerosis (MS) affects each person differently. The most common types of MS are: Relapsing-Remitting MS (RRMS) Secondary-Progressive MS (SPMS) Primary-Progressive MS (PPMS) Initially, most people with MS experience symptom […]
Read News ArticleWho Gets MS?
For decades, the number of people living in the United States with MS has been estimated at 400,000. However, no system or database exists to provide an exact figure, and […]
Read News ArticleThe MS Process
Multiple sclerosis (MS) is a disease of the central nervous system (CNS). The CNS consists of the brain, optic nerves, and spinal cord. With MS, areas of the CNS become […]
Read News ArticleHistory
The fact that MS symptoms flare up and subside, combined with the unpredictability of symptoms, has made MS a difficult disease to recognize, define, and treat. Since the late 1300s, […]
Read News ArticleIntroduction
Multiple sclerosis (MS) is an unpredictable disorder that can cause a variety of symptoms, which for many, can flare up and then subside over the course of days, months, or […]
Read News ArticleAbout MS
Second Edition View/Download PDF Order a Copy An Overview of Multiple Sclerosis (MS), Including MS Facts, Treatments, and Symptoms Written by: Susan Wells Courtney Reviewed by: Jack Burks, MD Edited […]
Read News ArticleFDA Approves Three-Times Weekly Dose of Glatopa®
Sandoz, a Novartis division, announced today that the United States Food and Drug Administration (FDA) approved Glatopa® (glatiramer acetate injection) at a three-times weekly 40-mg dose. This generic version of […]
Read News Article